Psychiatry Research xx (2007) xxx – xxx
Predicting therapeutic response to secondary treatment with bupropion:
Dichotic listening tests of functional brain asymmetry
Gerard E. Bruder ⁎, Jonathan W. Stewart, Jennifer D. Schaller, Patrick J. McGrath
Department of Psychiatry, Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute,
1051 Riverside Drive, New York, NY 10032, United States
Received 5 October 2006; received in revised form 9 March 2007; accepted 7 April 2007
Studies using neuroimaging, electrophysiologic and cognitive measures have raised hopes for developing predictors of
therapeutic response to antidepressants. Pretreatment measures of functional brain asymmetry have been found to be related toresponse to the selective serotonin reuptake inhibitor fluoxetine. This report examines the extent to which dichotic listening testsalso predict clinical response to an antidepressant with a different mechanism of action, i.e., bupropion. Dichotic listening datawere obtained for 17 unmedicated depressed patients who were subsequently treated with bupropion. Right-handed outpatientswere tested on dichotic fused-words and complex-tones tests. Seven patients who responded to bupropion and 10 nonrespondersdid not differ in gender, age or education. Bupropion responders had significantly larger left-hemisphere advantage for perceivingwords when compared to nonresponders, but there was no difference in their right-hemisphere advantage for tones. All patientshaving a left-hemisphere advantage above the normal mean responded to bupropion, whereas only 9% of patients below the normalmean responded to treatment. These findings should encourage further study of the clinical value of dichotic listening and othermeasures of functional brain asymmetry for identifying depressed patients who most benefit from treatment with different classesof antidepressants. 2007 Elsevier Ireland Ltd. All rights reserved.
Keywords: Depression; Bupropion; Treatment response; Dichotic listening; Hemispheric asymmetry
Although a variety of antidepressants with different
mechanisms of action are available for treatment of de-
pression, clinicians have no way of knowing in advance
whether or not a given patient will benefit from treat-
ment with a specific agent. Patients often must endure a
brain function suggest that pretreatment differences
prolonged “trial and error” period before finding an
among depressed patients are associated with respon-
effective antidepressant, and they may become increas-
siveness to antidepressants, raising hopes for identifying
ingly hopeless if they fail to benefit and discontinue
predictors of clinical response to antidepressants. It isnot, however, known whether these findings are asso-
ciated with a specific class of antidepressants, e.g., se-
Corresponding author. Tel.: +1 212 543 5468; fax: +1 212 543 6540.
lective serotonin reuptake inhibitors (SSRIs), or are
0165-1781/$ - see front matter 2007 Elsevier Ireland Ltd. All rights reserved. doi:
Please cite this article as: Bruder, G.E. et al. Predicting therapeutic response to secondary treatment with bupropion: Dichotic listening tests offunctional brain asymmetry. Psychiatry Research (2007), do
G.E. Bruder et al. / Psychiatry Research xx (2007) xxx–xxx
common to antidepressants with different mechanisms
mental disorder, history of head trauma, or other
neurological disorder. They were also excluded if they
Studies using dichotic listening tests indicate that
had a hearing loss greater than 30 dB in either ear at 500,
pretreatment measures of functional asymmetry of the
1000 or 2000 Hz or if they had an ear difference greater
right–left brain are related to subsequent responsiveness
than 10 dB. All participants gave written informed
consent before participating in the study. Diagnostic
assessment was by Structured Interview for Clinical
dichotic listening tests, different stimuli (e.g., words or
tones) are simultaneously presented to the left and right
conducted by research psychiatrists before dichotic
ears and the advantage for hearing items in the right or
listening tests. Patients met DSM-IV criteria for major
left ear, referred to as perceptual asymmetry (PA),
depressive disorder or, in one case, dysthymia. All find-
provides a measure of the advantage of the contralateral
ings reported below for the full sample were confirmed
hemisphere for processing verbal or tonal information.
after excluding the one dysthymic patient.
Unmedicated depressed patients at two clinical centers
Before being treated with bupropion, the patients
who subsequently responded favorably to fluoxetine
participated in a fluoxetine treatment study (n = 14) or
differed from nonresponders in showing greater left-
were treated openly with fluoxetine (n = 3). Their daily
hemisphere advantage for perceiving dichotic words and
fluoxetine dose was titrated to a maximum of 40–80 mg
less right-hemisphere advantage for perceiving complex
over a period of up to 12 weeks. All but 4 of these
patients were judged to be fluoxetine nonresponders
listening between fluoxetine responders and nonrespon-
using Clinical Global Impression Improvement (CGI-I)
ders was replicated in two additional studies, and was
criteria of minimal or no improvement. The remaining 4
found to be dependent on gender in both studies
patients responded to fluoxetine treatment but relapsed
). The heightened left-hemisphere advantage
or had side effects. These patients were subsequently
for words in fluoxetine responders was present among
treated with the SR formulation of bupropion. Twelve
women but not men, whereas reduced right-hemisphere
patients received bupropion within an 8 week open label
advantage for tones in responders was present among
study and 5 patients received open clinical treatment,
beginning with a daily dose of 100 or 150 mg and
The clinical value of dichotic listening or other tests
titrating to a maximum dose of 400 mg (except for one
for predicting treatment response would be strengthened
patient who received 600 mg). Only patients who
if they also indicated whether an alternative treatment
received a minimum of 6 weeks of bupropion treatment
would benefit patients who are not likely to respond to
an SSRI, the usual initial treatment. This report presents
A research psychiatrist blind to dichotic listening
dichotic listening data for patients who were treated with
data reviewed each patient's chart to determine
bupropion after, in most cases, unsuccessful treatment
treatment response independent of knowledge of the
with the SSRI fluoxetine. We examined whether dichotic
dichotic listening results. To be considered a “respond-
listening tests obtained before treatment would pre-
er” (R) the chart had to document a marked clinical
dict clinical response to bupropion and, if so, whether
improvement in the patient's depression, as indicated by
differences between bupropion responders and nonre-
chart notes such as “depression much improved”,
sponders are similar to or different from those seen for
“remitted”, “no longer depressed”, “feeling well” or
similar assessments within four weeks of the patientstarting on their maximal dose. In addition, improve-
ment had to be sustained for at least 4 weeks. In fourcases where there was not 4 weeks follow-up after their
initial benefit, their response was determined to be asindicated in their last chart note. Patients judged to be a
Patients were right-handed depressed outpatients
“nonresponder” (NR) had descriptors indicating mini-
between the ages of 20 and 64 who were attending a
mal or no clinical improvement, including “no benefit”,
university-affiliated research clinic. Patients were ex-
“no change”, “minimal improvement” or “much worse”.
cluded for any of the following reasons: serious suicide
In most cases, a treatment call was based on outcome at
risk, substance abuse disorders (including alcohol
the end of 8th week of treatment or in four patients who
abuse) within the last 6 months, psychotic disorders,
stopped treatment at the 7th week, the last available visit
antisocial personality disorder, seizure disorder, organic
Please cite this article as: Bruder, G.E. et al. Predicting therapeutic response to secondary treatment with bupropion: Dichotic listening tests offunctional brain asymmetry. Psychiatry Research (2007), doi
G.E. Bruder et al. / Psychiatry Research xx (2007) xxx–xxx
scores were used to compute an index of perceptualasymmetry, PA = 100 (Right Correct − Left Correct) /
Dichotic listening tests were administered during a
(Right Correct + Left Correct). A 2 by 2 repeated mea-
pretreatment session before patients received treatment
sures ANOVA was performed using one between-
with fluoxetine and then bupropion. Patients were
subject variable of Bupropion Response (R, NR) and
unmedicated a minimum of 7 days before dichotic
one repeated-measure variable of Test (words, tones),
listening testing, although most patients were drug-free
with PA scores being the dependent variable. If a sig-
for a considerably longer period or were not previously
nificant interaction of Bupropion Response and Test was
treated with an antidepressant. No patient was tested
present, separate t-tests were planned to evaluate wheth-
within 6 weeks of receiving fluoxetine or 1 week of
er responders and nonresponders differed on the indi-
receiving other antidepressants and no patient had
received a monoamine oxidase inhibitor. All patients
The potential value of PA scores for predicting thera-
and controls were tested on the dichotic fused-words
peutic response to bupropion was examined using a χ2
and complex-tones tests described below, with the order
test to compare response rates of patients with PA scores
of the tests counterbalanced across subjects.
above versus below the mean for healthy adults. Sensi-
tivity, specificity, positive predictive value and negative
consists of 15 different single-syllable word pairs, in
predictive value were also computed.
which each member of every pair differs from the otheronly in the initial consonant (e.g., coat, goat). All words
begin with one of six stop consonants (b, d, p, t, g, k) andare natural speech spoken by a male voice. When di-
There were 7 bupropion responders (5 men) who did
chotically presented, the members of each pair fuse into a
not differ significantly from the 10 nonresponders (6 men)
single percept. Participants indicate what word they heard
in gender, age (R mean = 43.3 yrs, S.D. = 12.1; NR
by marking a line through it on a prepared answer sheet
mean = 40.5 yrs, S.D. = 9.7; t = 0.53, df = 15, ns), education
that has four possible responses, both members of the
(R mean = 16.7 yrs, S.D. = 3.2; NR mean = 14.9 yrs, S.D. =
dichotic pair and two other words differing from the
2.3; t = 1.36, df = 15, ns) or handedness laterality quotient
dichotic stimuli only in the initial consonant. Following
(R mean = 84.4, S.D. = 21.0; NR mean = 84.7, S.D. = 18.2;
practice trials, each participant received four 30-item
t = 0.03, df = 15, ns) on the Edinburgh Inventory (
blocks for a total of 120 trials. Orientation of headphones
). The responder and nonresponder groups also had
was reversed after the first and third quarters to control for
comparable diagnoses. All met DSM-IV criteria for
channel differences and ear of presentation. The words
MDD, except for one nonresponder who met criteria for
were presented via a matched pair of TDH-49 headphones
dysthymia. Two responders also had a panic disorder and
at a comfortable level of 75 dB sound pressure level (SPL).
three nonresponders had comorbid anxiety disorders
(panic disorder, social phobia or obsessive–compulsive
cipants to compare the pitch of a binaural complex tone
disorder). Two patients in each group met DSM-IV
with the pitches of a dichotic pair of complex tones pre-
criteria for atypical depression and an additional two
sented 1 s earlier. Subjects point to a response card labeled
responders and three nonresponders showed the essential
Yes when the probe tone is the same as either member of
feature of reactivity of mood and one of four associated
the previous dichotic pair or to a card labeled No when it
differs from both. The complex tones are square waves
The responders and nonresponders also did not differ in
with fundamental frequencies corresponding to eight
pretreatment severity of depression on the Beck Depres-
notes in the octave between C4 and C5. After 16 binaural
and 16 dichotic practice trails, participants were tested on
session, when dichotic listening tests were performed
four blocks of 28 trials in which half of the probe tones
(R mean = 19.4, S.D. = 8.0; NR mean = 25.8, S.D. = 9.1;
matched a member of the dichotic pair and half did not.
t = 1.49, df = 15, ns). Also, pretreatment BDI scores were
Orientation of headphones was reversed after the first and
not related to PA for either words (r = −0.05, ns) or tones
third blocks. The tones were presented at 74 dB SPL.
gives the PA scores for bupropion responders
and nonresponders on the dichotic word and tone tests. Dashed lines show the mean left-hemisphere advantage
Correct responses in the words and tones tests were
for words (i.e., positive PA scores) and right-hemisphere
computed for right- and left-ear presentations. These
advantage for tones (i.e., negative PA scores) for 101
Please cite this article as: Bruder, G.E. et al. Predicting therapeutic response to secondary treatment with bupropion: Dichotic listening tests offunctional brain asymmetry. Psychiatry Research (2007), do
G.E. Bruder et al. / Psychiatry Research xx (2007) xxx–xxx
Fig. 1. PA scores for individual bupropion responders and nonresponders, and mean PA score for 101 normals on the fused-words and complex-tones tests.
responded to bupropion had a marked left-hemisphere
The patients also showed the expected difference
advantage for words that was greater than the normal mean
in PA for words and tones (main effect of Test: F = 31.17,
(dashed line). In contrast, all those who did not respond to
df = 1,15, P b 0.001). There was also a significant inter-
bupropion had little or no left-hemisphere advantage, i.e.,
action between Bupropion Response and Test (F = 6.99,
their PA scores were less than the normal mean. Patients
df = 1,15, P = 0.018). Separate analyses of PA scores for
who failed to respond to fluoxetine tended to show a normal
each test showed that responders had markedly larger
right-hemisphere advantage for tones, which did not differ
left-hemisphere advantage for words when compared to
between bupropion responders and nonresponders.
nonresponders (t = 4.06, df = 15, P = 0.001), but there
Given the marked difference between bupropion
was no group difference in right-hemisphere advantage
responders and nonresponders in PA scores for words,
for tones (t = 0.36, df = 15, ns), which accounts for this
we further evaluated their potential value for predicting
interaction. Although gender was not included as a
outcome of treatment. As in our prior studies (
variable in the ANOVA because cell sizes would be too
small, inspection of the data for individual men (closed
(dashed line in as a cutoff score for dividing
points) and women (open points) in suggests that
patients into those with relatively large versus small left-
gender was not a factor. The 5 male responders had
hemisphere advantage and a comparison was made
significantly larger left-hemisphere advantage for words
of their treatment response. All 6 of the patients with a
when compared to the 6 male nonresponders (t = 2.62,
left-hemisphere advantage above the normal mean re-
df = 9, P b 0.05) and the same difference was seen be-
sponded to bupropion, whereas only one of 11 patients
tween 2 female responders and 4 female nonresponders
with a left-hemisphere advantage less than the normal
mean responded to bupropion (χ2 = 13.25, P b 0.001).
Among patients who previously failed to benefit from
Thus, using this cutoff score to predict bupropion re-
fluoxetine (circles in ), all those who subsequently
sponse, the words test had high sensitivity (85.7%),
Please cite this article as: Bruder, G.E. et al. Predicting therapeutic response to secondary treatment with bupropion: Dichotic listening tests offunctional brain asymmetry. Psychiatry Research (2007), doi
G.E. Bruder et al. / Psychiatry Research xx (2007) xxx–xxx
specificity (100%), positive predictive value (100%), and
The difference in asymmetry for perceiving dichotic
words between patients who do or do not respond fa-
We also examined whether or not there were differ-
vorably to bupropion is in general similar to that pre-
ences between bupropion responders and nonresponders
in absolute accuracy scores for perceiving tones pre-
sented to the left and right ear. A 2 (Bupropion Reponse)
pathophysiology of patients who respond to these
by 2 (Ear) ANOVA revealed the expected left ear (right
different classes of antidepressant. In this regard, an
hemisphere) advantage for tones (F = 9.49, df = 1,15,
extensive STAR⁎D clinical trial found that depressed
P b 0.01), but there was no significant difference in
patients who had unsuccessful treatment with an SSRI
accuracy between groups (F = 1.04, df = 1,15, ns). There
showed about the same remission of symptoms after
was also no Bupropion Response by Ear interaction
switching to a different SSRI, bupropion or venlafaxine
(F = 0.35, df = 1,15, ns), which supports the lack of a
group difference in right-hemisphere advantage for
The gender differences for predicting response to
tones. Since words on the Fused Rhymed Words Test
fuse to form a single percept and subjects report only a
hold for bupropion. Our prior studies showed that
single word on each trial, they are close to 100% correct
heightened left-hemisphere advantage for dichotic
for reporting the word heard in either ear and therefore
words predicted positive fluoxetine response for women
the above analysis was not performed for the word test.
but not men. In the current study, 3 of the 4 patients with a
There was no difference in the number of errors made by
left-hemisphere advantage greater than normal who
responders (mean = 1.7, S.D. = 2.3) and nonresponders
nevertheless failed to respond to fluoxetine were men
(mean = 2.2, S.D. = 2.7; t = 0.38, df = 15, ns).
(see Although sample sizes were small, men whoresponded to bupropion had significantly larger left-
hemisphere advantage for words when compared tononresponders and this difference was also apparent for
This study presents the first evidence that pretreatment
women. Also, men who responded to fluoxetine differed
asymmetry on a dichotic words test predicts who will or
from nonresponders in showing reduced right-hemisphere
will not benefit from secondary treatment with the
antidepressant bupropion. Among depressed patients,
this difference was not found between bupropion
most of whom failed to respond to fluoxetine, those who
responders and nonresponders. Given that most of the
subsequently responded to bupropion had markedly
patients who were treated with bupropion had previously
larger left-hemisphere advantage for words when com-
failed to respond to fluoxetine, their normal right-
pared to nonresponders. All patients having above normal
hemisphere advantage is understandable. Thus, men
left-hemisphere advantage for words responded well to
who have both larger than normal left-hemisphere
treatment with bupropion, whereas those having less than
advantage for words and right-hemisphere advantage for
normal or no left-hemisphere advantage had only a 9%
tones may benefit more from treatment with bupropion
response rate to bupropion. The words test showed both
than fluoxetine. Women who have a larger than normal
high sensitivity (87.5%) and specificity (100%) for
left-hemisphere advantage for words would be expected
predicting response to bupropion. The value of dichotic
to respond well to fluoxetine, but if they fail to respond,
listening tests for predicting clinical response to the SSRI
they should nonetheless benefit from treatment with
fluoxetine was demonstrated in our prior studies (
bupropion, whereas those with little or no left-hemisphere
advantage may have a poor response to either antidepres-
words test showed moderately high sensitivity (76.3%)
sant. Although increased left-hemisphere advantage for
and specificity (85.7%) for predicting response to
words appeared to be present for both men and women
fluoxetine in women, but not in men. Examination of
who responded to bupropion, a study in a larger sample
the treatment response for patients with less than normal
is needed to more adequately evaluate gender effects for
left-hemisphere advantage () indicates that the word
test has high negative predictive value (i.e., nonresponder
An important question that needs further research is
rate for patients predicted to be nonresponders) for both
why hemispheric asymmetry for perceiving dichotic
bupropion (90.9%) and fluoxetine (81.8%). Thus, the
words is related to outcome of treatment with anti-
dichotic word test may prove to be particularly useful as a
depressants. Pretreatment differences in dichotic listen-
clinical predictor of patients who are likely to be treatment
ing asymmetry between fluoxetine responders and
nonresponders did not change following treatment,
Please cite this article as: Bruder, G.E. et al. Predicting therapeutic response to secondary treatment with bupropion: Dichotic listening tests offunctional brain asymmetry. Psychiatry Research (2007), do
G.E. Bruder et al. / Psychiatry Research xx (2007) xxx–xxx
which suggests that they represent stable, trait char-
randomly assigned to treatment with either bupropion or
an SSRI, is clearly needed to confirm the value of the
characteristic tendency for relatively greater left than
dichotic word test for predicting response to treatment
right-hemisphere activation is associated with better
with these different antidepressants.
treatment response. This hypothesis is supported by
electrophysiologic evidence of differences in hemi-
promise of the STAR⁎D trial may be in the identifica-
spheric asymmetry between fluoxetine responders and
tion of predictors of antidepressant response, which
would permit more individualized treatment of de-
maging studies have found that differences in hemi-
pressed patients. Our findings should encourage further
spheric activity in left frontal or temporal lobe regions
study of the clinical value of dichotic listening and other
are related to response to SSRI or other antidepressants
measures of functional brain asymmetry for identifying
depressed patients who will most benefit from treatment
One possible explanation for these findings
with different classes of antidepressants.
is that neurotransmitter systems affected by antidepres-sants may have an asymmetric distribution in the brain
or may be asymmetrically disturbed in treatment respon-sive or nonresponsive subtypes of depression.
This research was supported in part by a National
Some limitations of this study should also be dis-
Institute of Mental Health grant MH36295.
cussed. First, the patients in this study were participantsin an open label study or received open clinical treat-
ment. Although they received systematic treatment withbupropion, there was no active control (e.g., an SSRI) or
Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., 1961.
placebo control group. We therefore cannot rule out
An inventory for measuring depression. Archives of General
possible placebo effects and the specificity of the
Bruder, G.E., Otto, M.W., Stewart, J.W., McGrath, P., Fava, M.,
findings to bupropion will need further study. Second,
Rosenbaum, J.F., Quitkin, F.M., 1996. Dichotic listening before
all patients were treated with fluoxetine, most of whom
and after fluoxetine treatment for major depression: relations of
failed to respond, before being treated with bupropion.
laterality to therapeutic response. Neuropsychopharmnacology 15,
This limits the generalizability of the findings to patients
receiving secondary treatment with bupropion. Third,
Bruder, G.E., Stewart, J.W., Tenke, C.E., McGrath, P.J., Leite, P.,
Bhattacharya, N., Quitkin, F.M., 2001. Electroencephalographic
the categorization of the patients’ treatment response
and perceptual asymmetry differences between responders and
was based on chart review. A psychiatrist, who was
nonresponders to an SSRI antidepressant. Biological Psychiatrty
blind to the dichotic listening data, gave a treatment
response call on the basis of the patient's global clinical
Bruder, G.E., Stewart, J.W., McGrath, P.J., Deliyannides, D., Quitkin,
improvement. Although we did not use a predetermined
F.M., 2004. Dichotic listening tests of functional brain asymmetrypredict response to fluoxetine in depressed women and men.
fixed-time point for deciding treatment outcome (e.g.,
Neuropsychopharmacology 29, 1752–1761.
Buchsbaum, M.S., Wu, J., Siegel, B.V., Hackett, E., Trenary, M.,
best possible estimate of clinical response over a
Abel, L., Reynolds, C., 1997. Effect of sertraline on regional meta-
relatively narrow treatment trial (7–11 weeks). Fourth,
bolic rate in patients with affective disorder. Biological Psychiatry 41,
given that all patients were treated with fluoxetine
Cook, I.A., Leuchter, A.F., 2001. Prefrontal changes and treatment
before receiving bupropion, it is possible that fluoxetine
response prediction in depression. Seminars in Clinical Neuropsy-
was still active and there was an interaction between
fluoxetine and bupropion effects. However, the dichotic
Dunkin, J.J., Leuchter, A.F., Cook, I.A., Kasi-Godey, J.E., Abrams, M.,
listening tests were administered before either treatment,
Rosenberg-Thompson, S., 2000. Executive dysfunction predicts
and the treatment response call was not made until after
nonresponse to fluoxetine in major depression. Journal of AffectiveDisorder 60, 13–23.
patients had received at least 7 weeks of treatment with
First, M., Spitzer, R., Gibbon, M., Williams, J., 1994. The structural
bupropion alone. Fifth, the number of patients in this
clinical interview for DSM-IV Axis I Disorders — Patient Edition
study was small. The number of responders and non-
(SCID-I/P, Version 2.0). Biometric Research Department, New
responders is, however, not unlike those in many prior
York State Psychiatric Institute, New York, N.Y.
studies of this kind and the sample sizes were sufficient
Hoehn-Saric, R., Schlaepfer, T.E., Greenberg, B.D., McLoed, D.R.,
Pearlson, G.D., Wong, S.H., 2001. Cerebral blood flow in obsessive–
to demonstrate significant differences between bupropion
compulsive patients with major depression: effect of treatment with
responders and nonresponders. A prospective, double-
sertraline or desipramine on treatment responders and non-responders.
blind study with larger samples, in which patients are
Psychiatry Research: Neuroimaging 108, 89–100.
Please cite this article as: Bruder, G.E. et al. Predicting therapeutic response to secondary treatment with bupropion: Dichotic listening tests offunctional brain asymmetry. Psychiatry Research (2007), doi
G.E. Bruder et al. / Psychiatry Research xx (2007) xxx–xxx
Kalayam, B., Alexopoulos, G.S., 2003. A preliminary study of left frontal
degree of treatment response in major depression: evidence from
region error negativity and symptom improvement in geriatric
brain electrical tomography analysis. American Journal of Psychiatry
depression. American Journal of Psychiatry 160, 2054–2056.
Liebowitz, M.R., Quitkin, F.M., Stewart, J.W., McGrath, P.J., Harrison,
Rubinow, D.R., 2006. Treatment strategies after SSRI failure — good
W.M., Rabkin, J., Tricamo, E., Markowitz, J.S., Klein, D.F., 1984.
news and bad news. The New Journal of Medicine 354 (12),
Phenelzine v imipramine in atypical depression: a preliminary
report. Archives of General Psychiatry 41, 669–677.
Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Stewart, J.W., Nierenberg,
Little, J.T., Ketter, T.A., Kimbrell, T.A., Dunn, R.T., Benson, B.E.,
A.A., Thase, M.E., Ritz, L., Biggs, M.M., Warden, D., Luther, J.F.,
Willis, M.W., Luckenbaugh, D.A., Post, R.M., 2005. Bupropion
Shores-Wilson, K., Niederehe, G., Fava, M., 2006. Bupropion-SR,
and venlafaxine responders differ in pretreatment regional cerebral
Sertraline, or Venlafaxine-XR after failure of SSRIs for depression.
metabolism in unipolar depression. Biological Psychiatry 57,
The New England Journal of Medicine 354 (12), 1231–1242.
Saxena, S., Brody, A.L., Ho, M.L., Zohrabi, N., Maidment, K.M., Baxter,
Mayberg, H.S., Brannan, S.K., Mahurin, R.K., Jerabek, P.A., Brickman,
L.R., 2003. Differential brain metabolic predictors of response to
J.S., Tekell, J.L., Silva, J.A., McGinnis, S., Glass, T.G., Martin,
paroxetine in obsessive–compulsion disorder versus major depres-
C.C., Fox, P.T., 1997. Cingulate function in depression: a poten-
sion. American Journal of Psychiatry 160, 522–532.
tial predictor of treatment response. NeuroReport 8, 1057–1061.
Sidtis, J.J., 1981. The complex tone test: implications for the assessment
Oldfield, R.C., 1971. The assessment and analysis of handedness: The
of auditory laterality effects. Neuropsychologia 19, 103–112.
Edinburgh Inventory. Neuropsychologia 9, 97–113.
Stewart, J.W., Quitkin, F.M., McGrath, P.J., Bruder, G.E., 1999. Do tri-
Papakostas, G.I., Worthington III, J.J., Iosifescu, D.V., Kinrys, G.,
cyclic responders have different brain laterality? Journal of Abnormal
Burns, A.M., Fisher, L.B., Homberger, C.H., Mischoulon, D.,
Fava, M., 2006. The combination of duloxetine and bupropion for
Taylor, B.P., Bruder, G.E., Stewart, J.W., McGrath, P.J., Halperin, J.,
treatment-resistant major depressive disorder. Depression and
Ehrlichman, H., Quitkin, F.M., 2006. Psychomotor slowing as a
predictor of fluoxetine nonresponse in depressed outpatients.
Pizzagalli, D., Pascual-Marqui, R.D., Nitschke, J.B., Oakes, T.R., Larson,
American Journal of Psychiatry 163, 73–78.
C.L., Abercrombie, H.C., Schaefer, S.M., Koger, J.V., Benca, R.M.,
Wexler, B.E., Halwes, T., 1983. Increasing the power of dichotic methods.
Davidson, R.J., 2001. Anterior cingulate activity as a predictor of
The fused rhymed words test. Neuropsychologia 21, 59–66.
Please cite this article as: Bruder, G.E. et al. Predicting therapeutic response to secondary treatment with bupropion: Dichotic listening tests offunctional brain asymmetry. Psychiatry Research (2007), do
Springtime outdoor safety Whether you're relaxing in the backyard, turning up your garden, hitting the pool, or exploring the great outdoors, here are some ways to help keep you and your family healthy this spring and summer: • Beware of bugs: mosquitoes, ticks, and other i
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Optimal Practice Review (OPR) Tetracyclines for acne vulgaris 1 Introduction The Chief Executive is asked to consider the following does not proceed as a technology appraisal does not proceed as an OPR developed using short clinical guideline is referred back through the topic selection process for development as a clin